Showing results (141-150 of 187) with videos related to
Sort By:
Pageof 19
The Journal of Urology|June 1, 1988
Retroperitoneal lymphadenectomy for testis tumor with nerve sparing for ejaculationM A Jewett, Y S Kong, S D Goldberg, et al.International Journal of Cancer|August 30, 2019
Searching for prognostic biomarkers for small renal masses in the urinary proteomeAshley Di Meo, Ihor Batruch, Marshall D Brown, et al.Physiological Reports|January 7, 2016
Transcriptional profiling and muscle cross-section analysis reveal signs of ischemia reperfusion injury following total knee arthroplasty with tourniquetJonathan B Muyskens, Austin D Hocker, Douglas W Turnbull, et al.Radiology|September 1, 1982
Investigation of impotence by internal pudendal angiography: experience with 73 casesR R Gray, A G Keresteci, E L St Louis, et al.Cancer|September 15, 1987
Nonoperative urinary diversion for malignant ureteral obstructionJ A Zadra, M A Jewett, A G Keresteci, et al.American Journal of Human Genetics|March 20, 2001
HPC2 variants and screen-detected prostate cancerD Vesprini, R K Nam, J Trachtenberg, et al.Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|November 1, 1995
Natural killer cell immunodeficiency in HIV disease is manifest by profoundly decreased numbers of CD16+CD56+ cells and expansion of a population of CD16dimCD56- cells with low lytic activityP F Hu, L E Hultin, P Hultin, et al.The Journal of Urology|May 1, 1997
Prognostic factors for relapse in stage I testicular seminoma treated with surveillanceP Warde, M K Gospodarowicz, D Banerjee, et al.Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|December 9, 2014
Knowledge of genetic testing for hereditary kidney cancer in Canada is lacking: The results of the Canadian national hereditary kidney cancer needs assessment surveyPhilippe D Violette, Suzanne Kamel-Reid, Gail E Graham, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2000
Serum human glandular kallikrein-2 protease levels predict the presence of prostate cancer among men with elevated prostate-specific antigenR K Nam, E P Diamandis, A Toi, et al.Pageof 19